中文
A condition may be “rare,” but no person should feel invisible.
At JY MedTech, we recognize the resilience of the rare disease community and the importance of continued collaboration across science and healthcare.
Today, we stand with patients, families, advocates, and researchers working to increase awareness and accelerate progress.
JYMed Peptide and PDHC Bring the Peptide Community Together to Discuss Efficient and Sustainable Manufacturing
On October 21, 2026, JYMed Peptide joined the Peptide Drug Hunting Consortium (PDHC) to host an international webinar...
0 Comments